Abstract
The gram-negative anaerobic oral bacterium Porphyromonas gingivalis initiates periodontal disease through fimbrial attachment to saliva-coated oral surfaces. To study the effects of immunomodulation on enhancement of subunit vaccination, the expression in E. coli and immunogenicity of P. gingivalis fimbrial protein (FimA) linked to the C-terminus of the cholera toxin B subunit (CTB) were investigated. Complementary DNAs encoding the P. gingivalis 381 fimbrillin protein sequence FimA1 (amino acid residues 1–200) and FimA2 (amino acid residues 201–337) were cloned into an E. coli expression vector downstream of a cDNA fragment encoding the immunostimulatory CTB. CTB-FimA1 and CTB-FimA2 fusion proteins synthesized in E. coli BL21 (DE3) cells were purified under denaturing conditions by Ni2+-NTA affinity column chromatography. Renaturation of the CTB-FimA1 and CTB-FimA2 fusion proteins, permitted identification of CTB-FimA pentamers and restored CTB binding activity to GM1-ganglioside to provide a biologically active CTB-FimA fusion protein. Mice orally inoculated with purified CTB-FimA1 or CTB-FimA2 fusion proteins generated measurable FimA1 and FimA2 IgG antibody titers, while no serum fimbrial IgG antibodies were detected when mice were inoculated with FimA1 or FimA2 proteins alone. Immunoblot analysis confirmed that sera from mice immunized with CTB linked to FimA1 or FimA2 contained antibodies specific for P. gingivalis fimbrial proteins. In addition, mice immunized with FimA2 or CTB-FimA2 generated measurable intestinal IgA titers indicating the presence of fimbrial antibody class switching. Further, mice orally immunized with CTB-FimA1 generated higher IgA antibody titers than mice inoculated with FimA1 alone. The experimental data show that the immunostimulatory molecule CTB enhances B cell-mediated immunity against linked P. gingivalis FimA fusion proteins, in comparison to immunization with FimA protein alone. Thus, linkage of CTB to P. gingivalis fimbrial antigens can increase subunit vaccine immunogenicity to provide enhanced protection against periodontal disease.
Similar content being viewed by others
References
Lamont, R. J., & Jenkinson, H. F. (1998). Life below the gun line: Pathogenic mechanisms of Porphyromonas gingivalis. Microbiology and Molecular Biology Reviews, 62, 1244–1263.
Hamada, S., Amano, A., Kimura, S., Nakagawa, I., Kawabata, S., & Morisaki, I. (1998). The importance of fimbriae in the virulence and ecology of some oral bacteria. Oral Microbiology and Immunology, 13, 129–138. doi:10.1111/j.1399-302X.1998.tb00724.x.
Lee, J.-Y., Sojar, H. T., Bedi, G. S., & Genco, R. J. (1992). Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infection and Immunity, 60, 1662–1670.
Amano, A., Sharma, A., Lee, J.-Y., Sojar, H. T., Raj, P. A., & Genco, R. J. (1996). Structural domains of Porphyromonas gingivalis recombinant fimbrillin that mediate binding to salivary praline-rich protein and statherin. Infection and Immunity, 64, 1631–1637.
Sojar, H. T., Lee, J.-Y., & Genco, R. J. (1995). Fibronectin binding domain of P. gingivalis fimbriae. Biochemical and Biophysical Research Communications, 216, 785–792. doi:10.1006/bbrc.1995.2690.
Sojar, H. T., Sharma, A., & Genco, R. J. (2002). Porphyromonas gingivalis fimbriae bind to cytokeratin of epithelial cells. Infection and Immunity, 70, 96–101. doi:10.1128/IAI.70.1.96-101.2002.
Jotwani, R., & Cutler, C. W. (2004). Fimbriated Porphyromonas gingivalis is more efficient than fimbriae-deficient P. gingivalis in entering human dendritic cells in vitro and induces inflammatory Th1 effector response. Infection and Immunity, 72, 1725–1732. doi:10.1128/IAI.72.3.1725-1732.2004.
Hajishengalis, G., Sojar, H., Genco, R. J., & DeNardin, E. (2004). Intracellular signaling and cytokine induction upon interactions of Porphyromonas gingivalis fimbriae with pattern-recognition receptors. Immunological Investigations, 33, 157–172. doi:10.1081/IMM-120030917.
DeNardin, A. M., Sojar, H. T., Grossi, S. G., Christersson, L. A., & Genco, R. J. (1991). Humoral immunity of older adults with periodontal disease to Porphyromonas gingivalis. Infection and Immunity, 59, 4363–4370.
Condorelli, F., Scalia, G., Cali, G., Rossetti, B., Nicoletti, G., & Lo Bue, A. M. (1998). Isolation of Porphyromonas gingivalis and detection of immunoglobulin A specific to fimbrial antigen in gingival crevicular fluid. Journal of Clinical Microbiology, 36, 2322–2325.
Isogai, H., Yoshimura, F., Suzuki, T., Kagota, W., & Takano, K. (1988). Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae. Archives of Oral Biology, 33, 479–485. doi:10.1016/0003-9969(88)90028-3.
Fan, Q., Sims, T., Sojar, H., Genco, R., & Page, R. C. (2001). Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes. Oral Microbiology and Immunology, 16, 144–152. doi:10.1034/j.1399-302X.2001.016003144.x.
Malek, R., Fisher, J. G., Caleca, A., Stinson, M., Van Oss, C. J., Lee, J.-Y., et al. (1994). Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. Journal of Bacteriology, 176, 1052–1059.
Weinberg, A., Belton, C. A., Park, Y., & Lamont, R. J. (1997). Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infection and Immunity, 65, 313–316.
Umemoto, I., & Hamada, N. (2003). Characterization of biologically active cell surface components of a periodontal pathogen. The roles of major and minor fimbriae of Porphyromonas gingivalis. Journal of Periodontology, 74, 119–122. doi:10.1902/jop.2003.74.1.119.
Arakawa, T., Yu, J., & Langridge, W. H. R. (2001). Synthesis of a cholera toxin B subunit-rotavirus NSP4 fusion protein in potato. Plant Cell Reports, 20, 343–348. doi:10.1007/s002990000312.
Kim, T. G., Befus, N., & Langridge, W. H. R. (2004). Co-immunization with an HIV-1 Tat transduction peptide-rotavirus enterotoxin fusion protein stimulates Th1 mucosal immune response in mice. Vaccine, 22, 431–438. doi:10.1016/j.vaccine.2003.07.015.
Dertzbaugh, M. T., & Elson, C. O. (1993). Comparative effectiveness of the cholera toxin B subunits and alkaline phosphatase as carrier for oral vaccines. Infection and Immunity, 61, 48–55.
Sun, J. B., Holmgren, J., & Czerkinsky, C. (1994). Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proceedings of the National Academy of Sciences of the United States of America, 93, 7196–7201. doi:10.1073/pnas.93.14.7196.
Weiner, H. L. (1994). Oral tolerance. Proceedings of the National Academy of Sciences of the United States of America, 91, 10762–10765. doi:10.1073/pnas.91.23.10762.
Hajishengallis, G., Ratti, P., & Harokopakis, E. (2005). Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors. The Journal of Biological Chemistry, 280, 38902–38913. doi:10.1074/jbc.M507326200.
Ogawa, T., Kusumoto, Y., Uchida, H., Nagashima, S., Ogo, H., & Hamada, S. (1991). Immunological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis. Biochemical and Biophysical Research Communications, 180, 1335–1341. doi:10.1016/S0006-291X(05)81342-7.
Ogawa, T. (1994). The potential protective immune responses to synthetic peptides containing conserved epitopes of Porphyromonas gingivalis fimbrial protein. Journal of Medical Microbiology, 41, 349–358.
Nagata, H., Sharma, A., Sojar, H. T., Amano, A., Levine, M. J., & Genco, R. J. (1997). Role of the carboxyl-terminal regions of Porphyromonas gingivalis fimbrillin in binding to salivary proteins. Infection and Immunity, 65, 422–427.
Kim, T. G., & Langridge, W. H. R. (2003). Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato. Plant Cell Reports, 21, 884–890.
Jespersgaard, C., Hajishengallis, G., Greenway, T. E., Smith, D. J., Russell, M. W., & Michalek, S. M. (1999). Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase I. Infection and Immunity, 67, 810–816.
Lee, J.-Y., Sojar, H. T., Amano, A., & Genco, R. J. (1995). Purification of major fimbrial proteins of Porphyromonas gingivalis. Protein Expression and Purification, 6, 496–500. doi:10.1006/prep.1995.1066.
Loesche, W. J., & Grossman, N. S. (2001). Periodontal disease as a specific, albeit chronic, infection: Diagnosis and treatment. Clinical Microbiology Reviews, 14, 727–752. doi:10.1128/CMR.14.4.727-752.2001.
Dertzbaugh, M. T., & Elson, C. O. (1993). Reduction in oral immunogenicity of the cholera toxin B subunits by N-terminal peptide addition. Infection and Immunity, 61, 384–390.
Liljeqvist, S., Stahl, S., Andreoni, C., Binz, H., Uhlen, M., & Murby, M. (1997). Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. Journal of Immunological Methods, 210, 125–135. doi:10.1016/S0022-1759(97)00170-1.
Mitchell, V. S., Philipose, N. M., & Sanford, J. P. (1993). The children’s vaccine initiative. National Academy Press.
Shin, E.-A., Lee, J.-Y., Kim, T.-G., Park, Y. K., & Langridge, W. H. R. (2006). Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. Protein Expression and Purification, 47, 99–109. doi:10.1016/j.pep.2005.09.005.
Acknowledgments
This study was supported by a grant to J.Y. Lee from the Korea Health 21 R&D Project (A050028) by Ministry of Health and Welfare, Republic of Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, TG., Huy, NX., Kim, MY. et al. Immunogenicity of a Cholera Toxin B Subunit Porphyromonas gingivalis Fimbrial Antigen Fusion Protein Expressed in E. coli . Mol Biotechnol 41, 157–164 (2009). https://doi.org/10.1007/s12033-008-9102-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-008-9102-3